Trademark Overview
On Friday, November 8, 2024, a trademark application was filed for AMP2 with the United States Patent and Trademark Office. The USPTO has given the AMP2 trademark a serial number of 98843894. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, August 20, 2025. This trademark is owned by Theradaptive, Inc.. The AMP2 trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Therapeutic proteins in the nature of bone morphogenetic proteins for use as a bone growth media for medical purposes, namely, the manufacture of implantable medical devices; Therapeutic proteins in the nature of bone morphogenetic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; pharmaceutical and medicinal preparations and substances for the treatment and prevention of bone and tissue diseases and disorders, musculoskeletal diseases and disorders, blood vessel diseases and damage, craniomaxillofacial diseases and damage, skin diseases and damage, bone and joint injuries, and cancer, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeu...
targetable bone morphogenetic proteins for use as an inducer of regenerative bone growth other than for medical or veterinary purposes
Implantable scaffolds comprising synthetic materials for maintaining tissue contour; implants consisting of synthetic materials; synthetic bone grafts; implants comprising natural, non-living materials; implantable scaffolds comprising synthetic materials, namely, fusion cages for spinal surgery and expandable spinal implants; bone void fillers comprised of synthetic materials; bone regeneration matrices being artificial biomaterials for augmentation of bone for medical purposes; soft tissue regeneration matrices being surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; implantable medical devices to regenerate, repair, or treat soft tissue and bone; medical and surgical devices, apparatus, and instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentation; artificial biomaterials for augmentation of bone for medical purposes, namely, synthetic materials for use in bone an...
Research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; scientific research and development; research and development of medical devices, apparatus, and implants for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine
